|
Published by: PJB Publications USA Inc.
Published: Sep. 1, 2003 - 200 Pages
Table of Contents
1 Executive Summary
- 1.1 Scope and Objectives of Report
- 1.2 Methodology
- 1.3 Market Overview
2 Testing Sample Types
- 2.1 Blood Tests
- 2.2 Hair Tests
- 2.3 Saliva Tests
- 2.4 Urine Tests
3 Conditions Evaluated by Emerging At Home Tests
- 3.1 Cancer
- 3.1.1 Colon Cancer
- 3.1.2 Prostate Cancer
- 3.2 Coronary Artery Disease
- 3.3 Drug Abuse
- 3.3.1 Alcohol
- 3.3.2 Cocaine
- 3.3.3 Marijuana
- 3.3.4 Methamphetamines
- 3.3.5 Tobacco
- 3.4 HIV/AIDS
- 3.5 Hepatitis C
- 3.6 Infertility
- 3.7 Urinary Disorders
- 3.8 Hormone Levels
- 3.8.1 Male
- 3.8.2 Female
- 3.9 Osteoporosis
- 3.10 Thyroid Disorders
4 Emerging At-Home Test Products
- 4.1 Cholesterol Tests
- 4.1.1 Lifestream Technologies’s Personal Cholesterol Monitor
- 4.1.2 Polymer Technology Systems’s PTS Panels Lipid Panel Test
- 4.1.3 Biosafe Laboratories’s Cholesterol Panel
- 4.1.4 Home Access Health’s Home Access Instant Cholesterol Test
- 4.1.5 CholesTrak’s Cholesterol Test
- 4.1.6 Chemcard Cholesterol
- 4.1.7 Worldwide Medical’s First Check
- 4.2 Infectious Disease Tests
- 4.2.1 HIV/AIDS: Home Access Health’s Home Access HIV Test
- 4.2.2 Hepatitis C: Home Access Hepatitis C Test
- 4.2.3 Urinary Tract Infection
- 4.2.4 Vaginal Infection: FemTek’s pHEM-ALERT
- 4.3 Fecal Occult Blood Tests
- 4.3.1 Biomerica’s EZ Detect Stool Blood Test
- 4.4 Drug Tests
- 4.4.1 Alcohol
- 4.4.2 Cocaine, Marijuana, Methamphetamine, Opiates
- 4.4.3 Tobacco
- 4.5 Hormone Tests
- 4.5.1 Male Hormones: FertilMARQ/VasMARQ
- 4.5.2 Male and Female Hormones: SureStep Menopause Predictor Test
- 4.5.3 Thyroid Hormones: Biosafe Laboratories’s TSH Test
- 4.6 Miscellaneous/Other Tests
- 4.6.1 Prothrombin Time Test (PTT): Avocet Medical’s AcuSure System and International
- Technidyne’s Prothrombin Time Test System
- 4.6.2 Bladder Cancer: Matritech’s NMP22 BladderChek Test
- 4.6.3 Breast Cancer: Biomerica’s Aware Pad
- 4.6.4 Prostate Cancer: Biosafe’s PSA4 Test
- 4.6.5 Bone Mass: Ostex International’s Osteomark NTx POC
5 Research and Development
- 5.1 Alzheimer’s Disease Testing
- 5.2 Rheumatoid Arthritis Testing
- 5.3 Infectious Disease Testing
- 5.3.1 Strep Throat
- 5.3.2 Mononucleosis
- 5.3.3 Influenza
- 5.3.4 H. pylori (Gastric Ulcer)
- 5.3.5 Lyme Disease
- 5.4 Future Diagnostic Products
- 5.4.1 Cholesterol Testing
- 5.4.2 Infectious Disease Testing
- 5.4.3 Fecal Occult Blood Testing
- 5.4.4 Drug Testing
6 Market Issues and Trends
- 6.1 Clinical Laboratory Improvement Amendments (CLIA)
- 6.2 Concerns With Non-Approved Tests
- 6.3 Physician Concerns vs Consumer Demands
- 6.4 Medical Device Amendment
7 Market Revenues and Forecasts
- 7.1 Total Market Analysis
- 7.1.1 Market Analysis and Methodology Concerns
- 7.2 Cholesterol Testing Market
- 7.3 Infectious Disease Testing Market
- 7.4 Fecal Occult Blood Testing Market
- 7.5 Drug Testing Market
- 7.6 Hormone Testing Market
- 7.7 Miscellaneous/Other Testing Market
8 Competitive Analysis
- 8.1 Competitor Companies: Current Market Shares
- 8.2 Product Cost Analysis
9 Selected Company Profiles
- 9.1 AccuTech, LLC
- 9.2 Advantage Diagnostic Corp.
- 9.3 Beckman Coulter, Inc.
- 9.4 Biomerica, Inc.
- 9.5 Biosafe Medical Technologies, Inc.
- 9.6 Chematics, Inc.
- 9.7 Embryotech Laboratories, Inc.
- 9.8 Helena Laboratories Corp.
- 9.9 Home Access Health Corp.
- 9.10 International Technidyne Corp. (ITC)
- 9.11 Lifestream Technologies, Inc.
- 9.12 Ostex International, Inc.
- 9.13 Phamatech, Inc.
- 9.14 Polymer Technology Systems, Inc.
- 9.15 Princeton BioMeditech Corp.
- 9.16 Psychemedics Corp.
- 9.17 Roche Diagnostics Corp.
- 9.18 Sun Biomedical Laboratories, Inc.
- 9.19 Worldwide Medical Corp.
10 Company Directory
AbstractAt-home diagnostic tests are easy to use, portable, and provide rapid, easy-to-read results. Home test kits are growing in popularity and scientific advancements in the accuracy of the tests have fueled demand and expansion of the types of tests available.
In order to help your organization make educated decisions in this rapidly growing market, Theta’s study offers an in-depth analysis of market composition and dynamics, market size estimates, competitors, demographics, and economic and regulatory issues relevant to the emerging at-home diagnostic testing market in the U.S.
Emerging at-home diagnostics markets analyzed include:
- Cholesterol
- Hormones
- Fecal occult blood
- Drug abuse
- HIV/AIDS
Please Note: Theta requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.
Get Full Details About This Report >>
|
